- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Multiple arterial grafting in CABG reduce long-term mortality in diabetes patients
![Multiple arterial grafting in CABG reduce long-term mortality in diabetes patients Multiple arterial grafting in CABG reduce long-term mortality in diabetes patients](https://medicaldialogues.in/h-upload/2020/02/05/750x450_123974-coronary-heart-disease.webp)
UK: In a new study published in the European Heart Journal, it was shown that compared to single arterial grafting (SAG), multiple arterial grafting (MAG) relatively reduced mortality and major adverse cardiac events (MACE) rates after coronary artery bypass grafting (CABG) up to 10 years.
Despite significant breakthroughs in medical care, coronary artery disease (CAD) has long been recognized as a major source of morbidity and death in people with diabetes mellitus (DM). In individuals with diabetes and multi-vessel coronary disease, CABG has proven to be a better approach of revascularization when compared to percutaneous coronary intervention. As a result, David P. Taggart and colleagues conducted a post-hoc examination of the influence of MAG on CABG outcomes based on diabetes status in the Arterial Revascularization Trial (ART).
At a 10-year follow-up, the primary objective was all-cause death, and the secondary endpoint was a composite of major adverse cardiac events (MACE). Patients were divided into two groups based on their diabetes condition (non-DM and DM) and grafting method (MAG vs. SAG). The study comprised 3020 participants, with 716 (23.7%) having diabetes. In all, 55.8% of non-DM patients were given MAG and 44.2% were given SAG, whereas 56.6% of DM patients were given MAG and 43.4% were given SAG.
The key findings of this study were as follows:
1. When compared to SAG, the usage of MAG was related to reduced 10-year mortality in both DM and non-DM patients.
2. The rate of 10-year MACE was similarly lower for MAG compared. SAG in both groups.
3. Deep sternal wound infections (DSWIs) were infrequent overall, but more prevalent in the MAG group compared to the SAG group in both non-DM (3.3 vs. 2.1%) and DM patients (7.9 vs. 4.8% ).
4. The insulin-treated individuals receiving MAG had the greatest prevalence of DSWI (9.6 vs. 6.3%, when compared with SAG).
In conclusion, MAG was linked with significantly decreased death rates at 10 years post coronary artery bypass grafting in diabetic patients in this post-hoc analysis of the ART. Patients with DM who were given MAG had a greater risk of developing DSWI, especially if they were insulin-dependent.
Reference:
Taggart, D. P., Audisio, K., Gerry, S., Robinson, N. B., Rahouma, M., Soletti, G. Jr., Cancelli, G., Benedetto, U., Lees, B., Gray, A., Stefil, M., Flather, M., Gaudino, M., Taggart, D., Ratnatunga, C., Westaby, S., Cook, J., Wallis, C., … Wos, S. (2022). Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial. In European Heart Journal. Oxford University Press (OUP). https://doi.org/10.1093/eurheartj/ehac199
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751